4 Results for "

cancer osaka thyroid

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "cancer osaka thyroid" in MCE Product Catalog:

Cat. No.: HY-169153
CAS No.: 1984784-12-4
Target:  

MAP3K

Research Areas:  

Inflammation/Immunology

Cot inhibitor-3 (Compound 33) is a potent and selective cancer osaka thyroid (COT) kinase inhibitor, with an IC50 of 4 nM. Cot inhibitor-3 can be used to prevent inflammation-driven lameness .
loading...
    loading...
Cat. No.: HY-159074
CAS No.: 1798303-75-9
Target:  

MAP3K

Research Areas:  

Inflammation/Immunology Cancer

Cot-IN-5 (compound 1) is a potent ATP-competitive inhibitor of cancer osaka thyroid (COT). Cot-IN-5 can block COT kinase autophosphorylation .
loading...
    loading...
Cat. No.: HY-P75921
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MAP3K8; Proto-Oncogene Serine/Threoine Protein Kinase; Prev. ESTF; Cot (cancer osaka thyroid) Oncogene; Prev. COT; Serine/Threonine-Protein Kinase Cot; Tumor Progression Locus 2; cancer osaka thyroid Oncogene; Tpl-2; Ewing Sarcoma Transformant; C-COT; AUR
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-178726
CAS No.: 1984784-10-2
Cot-IN-4 (compound 32) is a potent cancer osaka thyroid (COT) kinase inhibitor with an IC50 of 6 nM. Cot-IN-4 inhibits the phosphorylation of ERK (IC50: 60 nM) and inhibits TNFα release (IC50: 60 nM). Cot-IN-4 also inhibits the formation of the pro-inflammatory cytokine IL-1β (IC50: 0.2 μM) in Uric acid (HY-B2130)-stimulated macrophages. Cot-IN-4 can be used for the study of inflammatory diseases .
loading...
    loading...